PK-PD of Caspofungin (Cancidas) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

Trial Profile

PK-PD of Caspofungin (Cancidas) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Caspofungin (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Jul 2017 The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years. Last Verified in July 2015
    • 31 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top